Medications for Sleep Maintenance Insomnia in a 64-Year-Old Male
For this 64-year-old man with sleep maintenance insomnia (frequent awakenings), start with either suvorexant (10-20 mg), low-dose doxepin (3-6 mg), or eszopiclone (2-3 mg) as first-line pharmacologic options, with suvorexant or doxepin preferred given his age. 1
First-Line Medication Options for Sleep Maintenance
The 2017 American Academy of Sleep Medicine guidelines specifically identify medications effective for sleep maintenance insomnia 1:
Preferred Agents:
Suvorexant (orexin receptor antagonist): 10-20 mg at bedtime
Low-dose doxepin (heterocyclic): 3-6 mg at bedtime
Eszopiclone (benzodiazepine receptor agonist): 2 mg at bedtime (start dose for age 64)
Alternative Options:
- Zolpidem extended-release: Can address sleep maintenance but carries higher fall risk in older adults 1
- Temazepam: 15 mg, but benzodiazepines have significant risks in this age group (falls, cognitive impairment, dependence) 1
Critical Age-Related Considerations
At age 64, this patient is approaching the threshold where medication risks increase substantially 2:
- Reduced drug clearance increases sensitivity to sedative-hypnotics
- Higher fall risk with benzodiazepines and some Z-drugs
- Cognitive impairment risk more pronounced with benzodiazepines
- Always start at lowest available dose and titrate cautiously 2
Medications to AVOID
- Trazodone (50 mg): Despite common off-label use, evidence shows no benefit for sleep maintenance and carries cardiac risks
- Diphenhydramine/antihistamines: Anticholinergic effects particularly harmful in older adults; tolerance develops in 3-4 days
- Benzodiazepines as routine therapy: High risk of dependence, falls, and cognitive impairment outweighs benefits
- Melatonin: Not effective for sleep maintenance insomnia (only minimal benefit for sleep onset)
- Tiagabine: Not effective and should not be used
Treatment Algorithm
Step 1: Before any medication, ensure behavioral interventions are addressed 2, 6:
- Eliminate daytime napping (or limit to 30 minutes before 2 PM)
- Avoid caffeine, nicotine, alcohol in evening
- Maintain consistent sleep/wake times
- Bedroom only for sleep and sex
Step 2: If pharmacotherapy needed, choose based on patient factors:
- If concerned about next-day sedation or fall risk: Start doxepin 3 mg
- If patient has no respiratory issues and wants newer agent: Start suvorexant 10 mg
- If cost is a major concern: Eszopiclone 2 mg (generic available)
Step 3: Follow-up in 2-4 weeks to assess:
- Effectiveness on wake after sleep onset and number of awakenings
- Adverse effects (next-day sedation, dizziness, falls)
- Need for dose adjustment
Step 4: If first agent ineffective, switch to alternate first-line agent rather than increasing dose 7
Step 5: Consider combining with cognitive behavioral therapy for insomnia (CBT-I) for sustained long-term benefit 2, 6
Important Safety Warnings
- All hypnotics carry FDA warnings about next-day impairment, complex sleep behaviors ("sleep driving"), and behavioral changes 6
- Observational data link chronic hypnotic use to increased dementia risk, fractures, and major injuries in older adults 6, 8
- Use lowest effective dose and attempt to taper when conditions allow 7
- Long-term use (beyond 4-5 weeks) should include regular monitoring for effectiveness and adverse effects 7, 6
Common Pitfall to Avoid
The most common error is prescribing trazodone because it's familiar and inexpensive. Despite widespread off-label use, the evidence shows it does not improve sleep maintenance outcomes and carries risks of orthostatic hypotension, cardiac arrhythmias, and priapism 1, 5. The 2017 AASM guidelines explicitly recommend AGAINST its use 1.